Table 3. Univariate and multivariate Cox proportional hazards regression analysis of 3-lncRNA signature and clinical risk factors in the entire dataset.
| Characteristic | Univariate analysis | Multivariate analysis | ||
| HR (95%CI) | P-Value | HR (95%CI) | P Value | |
| Age (≥65 vs. <65) | 1.585 (1.023-2.456) | 0.039 | 1.025 (1.005-1.047) | 0.016 |
| Gender (male vs. female) | 0.800 (0.532-1.205) | 0.286 | ||
| TNM stage (III-IV vs. I-II) | 4.249 (2.143-8.424) | < 0.001 | 3.900 (1.962-7.752) | < 0.001 |
| Tumor stage (T3-T4 vs. T0-T2) | 2.720 (1.616-4.577) | < 0.001 | ||
| Lymph node metastasis (yes vs. no) | 2.455 (1.639-3.676) | < 0.001 | ||
| Distant metastasis (yes vs. no) | 2.321 (0.712-7.568) | 0.163 | ||
| Risk score (high vs. low) | 2.088 (1.403-3.108) | < 0.001 | 1.856 (1.243-2.770) | 0.002 |
Notes: Bold values indicate statistical significance (P<0.05).
Abbreviations: HR, hazard ratio; CI, confidence interval.